Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Cescon
University Health Network, Princess Margaret Hospital, Toronto ON Canada
Study Chair - John Hilton
Ottawa Hospital Research Institute
Study Chair - Moira Rushton
Ottawa Hospital Research Institute
Study Chair - Nathalie Levasseur
BCCA - Vancouver Cancer Centre
Study Chair - Stephen Chia
BCCA - Vancouver Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
Recruiting - Bcca - Kelowna
Kelowna, British Columbia, Canada
Recruiting - Bcca - Vancouver
Vancouver, British Columbia, Canada
Recruiting - Qeii Health Sciences Centre
Halifax, Nova Scotia, Canada
Recruiting - Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
Recruiting - Kingston Health Sciences Centre
Kingston, Ontario, Canada
Recruiting - Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
Recruiting - Odette Cancer Centre
Toronto, Ontario, Canada
Suspended - University Health Network
Toronto, Ontario, Canada
Recruiting - the Jewish General Hospital
Montreal, Quebec, Canada
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jun 2023
- Primary completion
- 31 Dec 2027
- Completion
- 30 Jun 2028
- Last update posted
- 7 May 2026
- Registered enrollment
- 484
- Registry id
- NCT05601440
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.